UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Cancer biotherapy & radiopharmaceuticals, ISSN 1557-8852, 1996
Journal
Cancer treatment reviews, ISSN 0305-7372, 2016, Volume 44, pp. 61 - 73
Hematology, Oncology and Palliative Medicine | Bone-targeted therapy | Bone metastasis | Chemotherapy | Skeletal related event | Castration resistant prostate cancer | New generation hormonal agents | Life Sciences & Biomedicine | Oncology | Science & Technology | Anilides - therapeutic use | Phenylthiohydantoin - therapeutic use | Humans | Bone Neoplasms - secondary | Male | Antineoplastic Agents - therapeutic use | Prostatic Neoplasms, Castration-Resistant - pathology | Denosumab - therapeutic use | Taxoids - therapeutic use | Diphosphonates - therapeutic use | Bone Neoplasms - drug therapy | Imidazoles - therapeutic use | Mitoxantrone - therapeutic use | Carcinoma - secondary | Pyridines - therapeutic use | Carcinoma - drug therapy | Radioisotopes - therapeutic use | Dasatinib - therapeutic use | Docetaxel | Androstenes - therapeutic use | Bone Density Conservation Agents - therapeutic use | Zoledronic Acid | Prostatic Neoplasms, Castration-Resistant - drug therapy | Radium - therapeutic use | Phenylthiohydantoin - analogs & derivatives | Care and treatment | Metastasis | Prostate cancer | Cancer | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 2014, Volume 32, Issue 4, pp. 362 - 364
Life Sciences & Biomedicine | Oncology | Science & Technology | Phenylthiohydantoin - therapeutic use | United States | Humans | Drugs, Investigational | Male | Antineoplastic Agents - therapeutic use | Drug Approval | Androstenols - therapeutic use | Oligopeptides - therapeutic use | Taxoids - therapeutic use | Diphosphonates - therapeutic use | Imidazoles - therapeutic use | Goserelin - therapeutic use | Mitoxantrone - therapeutic use | Prostatic Neoplasms - drug therapy | United States Food and Drug Administration | Antibodies, Monoclonal, Humanized - therapeutic use | Radioisotopes - therapeutic use | Docetaxel | Androstenes | Tissue Extracts - therapeutic use | Zoledronic Acid | Denosumab | Radium - therapeutic use | Phenylthiohydantoin - analogs & derivatives | Estramustine - therapeutic use | Index Medicus
Journal Article
European journal of nuclear medicine and molecular imaging, ISSN 1619-7070, 2001
Journal
Endocrine-related cancer, ISSN 1351-0088, 3/2010, Volume 17, Issue 1, pp. R53 - R73
Review | Oncology | Endocrinology & Metabolism | Life Sciences & Biomedicine | Science & Technology | Humans | Digestive System Neoplasms - radiotherapy | Antineoplastic Agents - therapeutic use | Yttrium Radioisotopes - pharmacokinetics | Octreotide - pharmacokinetics | Digestive System Neoplasms - drug therapy | Gallium Radioisotopes - therapeutic use | Digestive System Neoplasms - diagnostic imaging | Neuroendocrine Tumors - diagnostic imaging | Receptors, Somatostatin - analysis | Organometallic Compounds - therapeutic use | Yttrium Radioisotopes - therapeutic use | Somatostatin - analogs & derivatives | Radiopharmaceuticals - pharmacokinetics | Octreotide - analogs & derivatives | Organometallic Compounds - pharmacokinetics | Treatment Outcome | Clinical Trials as Topic | Combined Modality Therapy | Indium Radioisotopes - pharmacokinetics | Positron-Emission Tomography - methods | Octreotide - therapeutic use | Somatostatin - pharmacokinetics | Peptides, Cyclic - pharmacokinetics | Neuroendocrine Tumors - radiotherapy | Animals | Organotechnetium Compounds - pharmacokinetics | Positron-Emission Tomography - standards | Receptors, Somatostatin - drug effects | Gallium Radioisotopes - pharmacokinetics | Neuroendocrine Tumors - drug therapy | Peptides, Cyclic - therapeutic use | Quality of Life | Indium Radioisotopes - therapeutic use | Somatostatin - therapeutic use | Radiopharmaceuticals - therapeutic use | Index Medicus
Journal Article
The Journal of urology, ISSN 0022-5347, 2015, Volume 194, Issue 6, pp. 1537 - 1547
Urology | neoplasm metastasis | androgen antagonists | drug therapy | castration | prostatic neoplasms | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Phenylthiohydantoin - adverse effects | Phenylthiohydantoin - therapeutic use | Humans | Male | Antineoplastic Agents - therapeutic use | Prostatic Neoplasms, Castration-Resistant - pathology | Taxoids - therapeutic use | Neoplasm Metastasis - drug therapy | Antineoplastic Agents - adverse effects | Prostatic Neoplasms, Castration-Resistant - therapy | Taxoids - adverse effects | Radioisotopes - therapeutic use | Androstenes - adverse effects | Radioisotopes - adverse effects | Docetaxel | Tissue Extracts - adverse effects | Androstenes - therapeutic use | Survival Rate | Radium - adverse effects | Tissue Extracts - therapeutic use | Radium - therapeutic use | Disease Progression | Phenylthiohydantoin - analogs & derivatives | Orchiectomy | Taxoids - administration & dosage | Neoplasm Metastasis - pathology | Androgen Antagonists - therapeutic use | Prostatic Neoplasms, Castration-Resistant - mortality | Androgen Antagonists - adverse effects | Neoplasm Staging | Medical colleges | Care and treatment | Metastasis | Prostate cancer | Index Medicus | Abridged Index Medicus
Journal Article
CA: a cancer journal for clinicians, ISSN 0007-9235, 09/2012, Volume 62, Issue 5, pp. 309 - 335
Life Sciences & Biomedicine | Oncology | Science & Technology | Immunotherapy - methods | Dendritic Cells - immunology | Humans | Dendritic Cells - physiology | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Bevacizumab | Cancer Vaccines - therapeutic use | Neoplasms - therapy | Immunotherapy - trends | Angiogenesis Inhibitors - therapeutic use | Receptor, ErbB-2 - antagonists & inhibitors | Cetuximab | Yttrium Radioisotopes - therapeutic use | Gene Transfer Techniques | Histocompatibility Antigens - immunology | Antibodies, Monoclonal, Humanized - therapeutic use | Alemtuzumab | Vaccines, DNA - therapeutic use | alpha-Fetoproteins - therapeutic use | alpha-Fetoproteins - immunology | Neoplasms - immunology | Tumor Necrosis Factor Receptor Superfamily, Member 9 - antagonists & inhibitors | Receptor, Epidermal Growth Factor - antagonists & inhibitors | T-Lymphocytes - immunology | Genetic Vectors | Trastuzumab | Care and treatment | Usage | Research | Health aspects | Immunotherapy | Cancer | Immunology | Cancer therapies | Manipulation | Tumors | Index Medicus | Abridged Index Medicus
Journal Article